SOLX Launches New Glaucoma System

SOLX, a Boston University Photonics Center Company that develops glaucoma treatment systems, has commenced commercial operations after conducting four years of research and product development in the Photonics Center's Business Acceleration Program. SOLX's DeepLight Glaucoma Treatment System, which combines its Titanium Sapphire Laser and Gold Shunt, provides physicians a new approach to decreasing intraocular pressure, the primary risk factor for glaucoma. The new treatment system reduces compliance problems common in glaucoma sufferers.

ArriveNet (http://press.arrivenet.com/pro/article.php/600077.html)